Apimeds Pharmaceuticals US (APUS) Payables (2023 - 2025)
Apimeds Pharmaceuticals US (APUS) posted Payables of $7.1 million for Q4 2025, up 1149.27% on a QoQ basis from $567633.0 in Q3 2025, and up 743.0% year-over-year from $841191.0 in Q4 2024.
Apimeds Pharmaceuticals US (APUS) Payables (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US's Payables history runs 3 years deep, the most recent figure standing at $7.1 million for Q4 2025.
- Quarterly Payables rose 743.0% year-over-year to $7.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.1 million (up 743.0% YoY) and the FY2025 annual result came in at $7.1 million, up 743.0% from the prior year.
- Payables was $7.1 million for Q4 2025 at Apimeds Pharmaceuticals US, up from $567633.0 in the prior quarter.
- Across five years, Payables topped out at $7.1 million in Q4 2025 and bottomed at $119138.0 in Q2 2025.
- A 3-year average of $1.7 million and a median of $704412.0 in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables soared 161.78% — and 2025, when it surged 743.0%.
- Apimeds Pharmaceuticals US's Payables stood at $321329.0 in 2023, then jumped by 161.78% to $841191.0 in 2024, then jumped by 743.0% to $7.1 million in 2025.
- Business Quant data shows APUS's Payables at $7.1 million in Q4 2025, $567633.0 in Q3 2025, and $119138.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Apimeds Pharmaceuticals US | 8.17 Mn | 8.17 Mn | - | 7.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.09 Mn |
| Sep 30, 2025 | 567,633.00 |
| Jun 30, 2025 | 119,138.00 |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 841,191.00 |
| Dec 31, 2023 | 321,329.00 |